|Articles|August 20, 2019

Prospectus For Establishment of a DSCSA Governance Body

Click on the link below to read the document:

Final Governance Prospectus Document_080919

Newsletter

Stay ahead in the life sciences industry with Pharmaceutical Commerce, the latest news, trends, and strategies in drug distribution, commercialization, and market access.

Subscribe

Related Content

Containers rest on glowing blue circuit board path. Digital network infrastructure connects global shipping, logistics. | © miss irine - stock.adobe.com (1863323027)

Q&A: Why Pharma Supply Chains Are Turning to AI

ByNatalia Andreyeva,Stephen Appezzato

June 5th 2026

Ozempic Insulin injection pen or insulin cartridge pen for diabetics and weight loss. | © Kassandra - stock.adobe.com (1142156500)

FAQ: What Does the Medicare GLP-1 Bridge Mean for Pharma?

ByStephen Appezzato

June 5th 2026

How Pharma 3PLs Are Rethinking Their Role in Drug Commercialization

ByDanny Williams,Stephen Appezzato

June 4th 2026

Pharma Pulse: 340B Uncertainty, Drug Shortages, and Wegovy's Global Debut

ByStephen Appezzato

June 4th 2026

Wegovy Pill's UAE Debut Is a Distribution Story, Not Just a Market Entry

ByStephen Appezzato

June 3rd 2026

Prospectus For Establishment of a DSCSA Governance Body

Related Content

Q&A: Why Pharma Supply Chains Are Turning to AI

FAQ: What Does the Medicare GLP-1 Bridge Mean for Pharma?

How Pharma 3PLs Are Rethinking Their Role in Drug Commercialization

Pharma Pulse: 340B Uncertainty, Drug Shortages, and Wegovy's Global Debut

Wegovy Pill's UAE Debut Is a Distribution Story, Not Just a Market Entry

Trending on Pharmaceutical Commerce

FAQ: The Medicare GLP-1 Bridge Program

Q&A: Why Pharma Supply Chains Are Turning to AI

Q&A: Dr. Reddy's CEO on Generic Semaglutide and the GLP-1 Market Ahead

FAQ: What Does the Medicare GLP-1 Bridge Mean for Pharma?

Pharma Pulse: 340B Uncertainty, Drug Shortages, and Wegovy's Global Debut